Katie Badje
Physician Assistant · Rapid City, SDNPI 1407565914
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 109 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 17.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $1,403 and has fallen 77.3% since, to $318 in 2025. Among physician assistant clinicians in SD with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 109 payments — averaging $24.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$465
- Medtronic$292
- Lilly USA, LLC$254
- Abiomed$171
- Corcept Therapeutics$145
- Cequr Corporation$140
- plus $1K from 23 others
What the payments were for
- Food & beverage$2,713100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 27 | $465 |
| Medtronic | 4 | $292 |
| Lilly USA, LLC | 15 | $254 |
| Abiomed | 1 | $171 |
| Corcept Therapeutics | 2 | $145 |
| Cequr Corporation | 2 | $140 |
| AbbVie | 6 | $112 |
| Tandem Diabetes Care, Inc. | 3 | $110 |
| Mannkind Corporation | 3 | $97 |
| Sanofi-aventis U.S. LLC | 4 | $93 |
| Boehringer Ingelheim | 5 | $93 |
| Novo Nordisk | 4 | $82 |
| Amneal Pharmaceuticals LLC | 4 | $80 |
| Radius Health, Inc. | 4 | $78 |
| Recordati_rare_diseases_inc. | 4 | $78 |
| Dexcom, Inc. | 2 | $61 |
| Bayer | 3 | $48 |
| Rhythm Pharmaceuticals, Inc. | 2 | $43 |
| Ascensia Diabetes Care US Inc. | 2 | $40 |
| Xeris Pharmaceuticals, Inc. | 2 | $37 |
| Averitas Pharma Inc. | 1 | $28 |
| Insulet Corporation | 2 | $28 |
| Ascendis Pharma Endocrinology Inc | 1 | $27 |
| Atricure, Inc. | 1 | $25 |
| Novartis | 1 | $20 |
| IBSA Pharma Inc. | 1 | $19 |
| Amgen | 1 | $19 |
| Almatica Pharma LLC | 1 | $17 |
| Tolmar, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FREESTYLE LIBRE 3$279
- MINIMED 780G$140
- Korlym$125
- SYMPLICITY G3$122
How this compares
$2,713 in reported general payments places this provider in the 90th percentile of 548 physician assistant providers in South Dakota.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 130 | $174,254 |
| MounjaroTirzepatide | 76 | $95,050 |
| JardianceEmpagliflozin | 56 | $72,752 |
| TrulicityDulaglutide | 25 | $30,818 |
| Tresiba Flextouch U-200Insulin Degludec | 23 | $29,713 |
| FarxigaDapagliflozin Propanediol | 15 | $23,156 |
| Tresiba Flextouch U-100Insulin Degludec | 22 | $17,402 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 14 | $15,362 |
| SynthroidLevothyroxine Sodium | 121 | $12,444 |
| Synjardy XrEmpagliflozin/Metformin Hcl | 12 | $11,892 |
| Nano 2nd Gen Pen NeedlePen Needle, Diabetic | 25 | $3,068 |
| Humalog Kwikpen U-100Insulin Lispro | 16 | $2,924 |
| Levothyroxine Sodium | 321 | $2,800 |
| Novolog FlexpenInsulin Aspart | 13 | $2,650 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 17 | $2,317 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $82 | $174,254130 claims |
| Lilly USA, LLCMounjaro, Trulicity | $254 | $125,868101 claims |
| Boehringer IngelheimJardiance, Synjardy Xr | $93 | $84,64368 claims |
| AbbVieSynthroid, Armour Thyroid | $112 | $13,629135 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium, Unithroid | $80 | $3,730348 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 548 physician assistant providers in South Dakota.
Other physician assistant in Rapid City
- Jordan HeinsRapid City$10K
- Jarrett FowlerRapid City$7K
- Jerome WenningerRapid City$7K
- Kristi BrueningRapid City$5K
- Nicholas AlonzoRapid City$4K
- Kayla TollefsrudRapid City$4K
- Morgan SauvageRapid City$3K
- Paeton MoyleRapid City$3K
- Cassidy PetersonRapid City$3K
- Corey AndersonRapid City$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.